Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
Abstract Background The DecisionDx-Melanoma test provides prognostic information for patients with cutaneous melanoma (CM). Using formalin-fixed paraffin-embedded primary tumor tissue, the RT-PCR-based test classifies patients into a low- (Class 1) or high-risk (Class 2) category for recurrence base...
Saved in:
Main Authors: | Robert W. Cook (Author), Brooke Middlebrook (Author), Jeff Wilkinson (Author), Kyle R. Covington (Author), Kristen Oelschlager (Author), Federico A. Monzon (Author), John F. Stone (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients
by: Sherri Borman, et al.
Published: (2022) -
Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics
by: Kristen M. Plasseraud, et al.
Published: (2017) -
Treatment of Metastatic Melanoma
Published: (2011) -
Perforating metastatic melanoma
by: Takenobu Ohashi, et al.
Published: (2015) -
Metastatic melanoma with an unknown primary
by: Anuradha Kakkanatt Babu, et al.
Published: (2022)